Carl L Gordon

Director · 4 filings · Latest: Aug 10, 2026

BlossomHill Therapeutics, Inc.

Scribe Therapeutics, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
BLSM	Carl L Gordon	Director	Aug 10, 2026	Purchase	$16.00	625,000	$10.0M	2,714,279	Aug 12 8:46 PM
SCTX	Carl L Gordon	Director	Jul 27, 2026	Purchase	$15.00	1,000,000	$15.0M	1,348,825	Jul 29 10:50 PM